Immatics N.V. (IMTX) Social Stream



Immatics N.V. (IMTX): $11.27

0.05 (+0.45%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

Add IMTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#65 of 359

in industry

IMMATICS NV (IMTX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering IMMATICS NV.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-18 4 $30 $19 $24.25 $11.16 117.29%
2022-03-23 4 $32 $19 $25.25 $11.16 126.25%
2022-03-24 4 $30 $20 $23.75 $11.16 112.81%
2022-06-02 4 $30 $14 $22.25 $11.16 99.37%
2022-06-07 4 $30 $14 $22.5 $11.16 101.61%
2022-07-14 4 $30 $14 $20.25 $11.16 81.45%
2022-08-10 4 $28 $16 $20.25 $11.16 81.45%
2023-02-08 4 $28.9 $16 $20.475 $11.16 83.47%
2023-03-21 4 $28.9 $16 $20.225 $11.16 81.23%
2023-03-24 4 $25 $16 $19.25 $11.16 72.49%
2023-04-05 4 $25 $12 $17.8 $11.16 59.5%
2023-08-17 5 $25 $12 $17.8 $11.16 59.5%
2023-08-18 5 $25 $14 $18.4 $11.16 64.87%
2023-09-18 5 $25 $14 $18.8 $11.16 68.46%

The Trend in the Analyst Price Target


Over the past 33 months, IMTX's average price target has gone up $4.43.

Over the past 49 weeks, IMTX's average upside potential has been 117.6%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-11-18 4 28.9 16 20.475 10.55 94.08%
2023-04-05 5 25.0 12 17.800 6.45 175.97%
2023-06-06 5 25.0 12 17.800 10.59 68.08%
2023-08-17 5 25.0 12 17.800 11.60 53.45%
2023-08-18 5 25.0 14 18.400 12.21 50.7%

IMTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


Over the past 48 weeks, IMTX's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how IMMATICS NV fares relative to all US stocks, note that its number of analysts covering the stock is higher than 229.87% of that group.
  • In the context of all US stocks, IMMATICS NV's average analyst price target is higher than 389.76% of them.
  • In terms of how IMMATICS NV fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1053.51% of that group.
  • IMMATICS NV's variance in analysts' estimates is lower than -875.31% of stocks in the small market cap category.

Stocks similar to IMMATICS NV in the Pharmaceutical Products industry regarding analyst recommendations and price targets are STRO, CLLS, and ADAP.

What is the outlook for IMTX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!